Deal Hungry Novo Moves With ‘Intention’ To Put Metsera in the Rearview

Speaking on the sidelines of the J.P. Morgan Healthcare Conference, Novo business development executive Tamara Darsow said the company is gunning for obesity and diabetes assets.

Scroll to Top